U.S. Paper and Forestry Products Stock News

Recent performance snapshot Black Hills (BKH) has drawn fresh attention after a recent move in its share price, with the stock up 1.3% over the past day and 3.4% across the past week. That short term strength contrasts with a 4.7% decline over the past month and a 1.7% gain over the past 3 months, giving investors a mixed but active recent trading picture to assess. See our latest analysis for Black Hills. Looking beyond the recent rebound, Black Hills has a mixed share price pattern over...

Sphere Entertainment recently reported past-quarter revenue growth of 28%, powered by the success of its “Wizard of Oz at Sphere” production in Las Vegas, which has sold more than two million tickets and helped narrow operating losses in the Sphere segment. On the back of this stronger performance, the company is now moving ahead with international Sphere developments in Abu Dhabi and National Harbor, signaling a push to replicate its immersive venue model beyond the US. We’ll now examine...

If you are wondering whether Burlington Stores at around US$328.73 is offering good value today, you are not alone. This article focuses squarely on that question. The stock has posted returns of 2.7% over 7 days, 9.4% over 30 days, 10.2% year to date, 39.5% over 1 year, 69.5% over 3 years and 5.0% over 5 years. This naturally raises questions about what is already priced in and what might still be on the table. Recent coverage of Burlington Stores has highlighted how investors are...

In its recent past quarter, MYR Group reported US$973.5 million in revenue, up 17.3% year on year, beating analyst expectations on revenue, earnings per share, and EBITDA and extending a multi-quarter streak of earnings beats. Yet, relatively modest backlog growth, low gross margins, and a declining return on invested capital are raising questions about the durability of that strong operational performance. Now we’ll examine how this strong earnings beat, alongside concerns over backlog and...

Shopee has reached an official profitability milestone, marking a key shift in the economics of Sea's core e commerce business. SeaMoney has reported strong year over year gains in profitability and loan growth, pointing to deeper engagement across its digital financial services. Institutional investor Steve Cohen has increased his stake in Sea (NYSE:SE), signaling renewed interest from a high profile market participant. Sea (NYSE:SE) is trading at $82.28, after a 3.0% gain over the past...

Wondering if Modine Manufacturing at around US$219 per share is still sensibly priced, or if the easy part of the story is already behind it. The stock has posted returns of 1.6% over the last 7 days, 3.3% over 30 days, 55.8% year to date and 202.1% over the past year, with a very large gain of more than 7x over 5 years. Recent coverage has focused on Modine Manufacturing as a high-performing name in the capital goods space, with attention on how its share price history compares to peers and...

If you are wondering whether Kenvue's current share price reflects its true worth, this article walks through the key numbers so you can judge that for yourself. Kenvue last closed at US$17.14, with returns of a 2.4% decline over 7 days, a 5.6% decline over 30 days, a 1.0% decline year to date and a 24.3% decline over the past year, which may change how you think about its risk and potential reward profile. Recent headlines around Kenvue have focused on its position as a standalone consumer...

Brown & Brown stock: recent returns and business mix Brown & Brown (BRO) has drawn investor attention after a period of mixed share performance, with the stock showing negative total returns over the past year alongside multi year gains and solid reported revenue and net income figures. See our latest analysis for Brown & Brown. At a share price of US$65.95, Brown & Brown has seen short term share price pressure with a 30 day share price return of 8.61% and year to date share price return of...

Bicara Therapeutics Inc. has reported 2025 results showing a higher net loss of US$137.95 million while simultaneously bolstering its balance sheet through an oversubscribed public offering and filing a US$70.36 million shelf registration for additional common stock. Against this backdrop, the company’s lead candidate ficerafusp alfa secured FDA Breakthrough Therapy Designation and advanced into a pivotal Phase III trial, prompting renewed attention to how Bicara is balancing heavier losses...

Amazon is reported to be in advanced talks to acquire Globalstar, aiming to use its spectrum rights and satellite assets for Amazon's low Earth orbit internet network. The potential deal would position Amazon to compete more directly with SpaceX's Starlink in global satellite connectivity. Apple, which holds an estimated 20% economic interest in Globalstar and certain approval rights, is expected to be a key player in any transaction outcome. Globalstar (NasdaqGS:GSAT) has drawn intense...

Recent analyst actions toward Service Corporation International (SCI) have drawn fresh attention to the stock, as upbeat ratings and higher targets intersect with expectations for steady earnings and growing pre-need Cemetery sales. See our latest analysis for Service Corporation International. SCI’s recent 1-day share price return of 2.31% and 7-day share price return of 3.58% sit against a 90-day share price return of 9.81% and a 5-year total shareholder return of 77.92%. This highlights...

In recent days, General Dynamics has benefited from heightened geopolitical tensions in the Middle East, with new U.S. defense contracts and increased A-10 deployments lifting demand for its defense systems and related capabilities. This upswing has coincided with a broader boost to aerospace and defense companies as global defense spending rises and interest in innovations such as SpaceX’s confidential IPO filing grows. Now we’ll examine how increased Middle East deployments and related...

Recent share performance and basic profile First Citizens BancShares (FCNC.A) has drawn attention after recent price moves, with the stock showing a one-month return of a 3.4% decline and a past three-month return of an 11.7% decline against a last close of US$1,906.63. The US based bank holding company reports revenue of US$9.0b and net income of US$2.1b, supported by its General Bank, Commercial Bank, Rail and Corporate segments, all primarily focused on the United States market. See our...

Denali Therapeutics (NasdaqGS:DNLI) has regained full global rights to DNL593 for frontotemporal dementia granulin, after Takeda ended its collaboration. DNL593 uses Denali's TransportVehicle technology to deliver progranulin to the brain for patients with FTD-GRN. Denali plans to continue clinical development of DNL593 independently, with Phase 1/2 study results expected by the end of 2026. Denali Therapeutics focuses on treatments for neurodegenerative diseases, an area where current...

Why Hillman Solutions Is On Investors’ Radars Today Hillman Solutions (HLMN) is back in focus as investors weigh its recent share performance, with the stock roughly flat over the past month but showing a negative return over the past 3 months. Set against that backdrop, Hillman’s current market value of about US$1.62b, annual revenue of US$1.55b, and net income of US$40.31m give you a sense of the company’s scale in the hardware and home improvement products space. See our latest analysis...

In early April 2026, EXL announced a collaboration with Google Cloud to expand AI-led transformation services, helping clients scale enterprise AI, modernize data, and upgrade cloud infrastructure across financial services, healthcare, life sciences, utilities, and retail. A key insight is that EXL is deepening its Google Cloud practice with over 800 trained AI specialists and proven frameworks already used to automate complex, high-volume workflows for large enterprises, particularly in...

This article examines whether Estée Lauder Companies is attractively priced after a difficult period in the market, or whether the stock could still face further downside, by focusing on what the current share price might imply about value. The stock last closed at US$69.12, with a 0.9% decline over 7 days, a 30.0% decline over 30 days, a 35.3% decline year to date, a 20.7% gain over 1 year, and declines of 69.7% over 3 years and 75.1% over 5 years. Together, these figures present a mixed...

Hexcel Corporation recently entered into a new US$750 million revolving credit facility maturing in 2031, drawing US$300 million to refinance its prior credit agreement without penalties and securing funds for general corporate uses, including acquisitions and investments. The new facility’s flexible structure, potential for up to US$500 million in additional commitments, and covenant framework reshapes Hexcel’s balance sheet options and risk profile ahead of its upcoming first-quarter 2026...

If you are wondering whether Toast's current share price is fair, expensive, or offers value, this article walks through the numbers so you can judge that for yourself. Toast shares last closed at US$26.47, with recent returns of 0.3% over 7 days, a 9.1% decline over 30 days, a 22.2% decline year to date, and a 19.0% decline over 1 year, while the 3 year return stands at 59.9%. Recent coverage has focused on Toast's position in the restaurant technology space and its ability to scale its...

Cencora (NYSE:COR) has signed a binding agreement to acquire the retina division of EyeSouth Partners, expanding its Retina Consultants of America network. The transaction centers on advanced retina care services and is intended to deepen Cencora's presence in ophthalmology-focused healthcare offerings. The company also announced the planned retirement of Chief Financial Officer James F. Cleary and has initiated an executive search for his successor. Cencora operates across pharmaceutical...

KalVista Pharmaceuticals recently reported new interim results from its KONFIDENT-KID trial, showing that EKTERLY (sebetralstat) oral disintegrating tablets treated 172 hereditary angioedema attacks in 33 children aged 2–11 with rapid symptom relief and no serious or treatment-related adverse events. The data highlight how an easy-to-administer oral option could address a major gap in pediatric hereditary angioedema care, where current on-demand treatment for young patients in the US is...

CME Group (NasdaqGS:CME) reports record trading volumes across all product categories. The company launches 24/7 trading for regulated cryptocurrency futures and options. CME partners with BMO and Google Cloud to roll out 24/7 tokenized cash settlement for institutional clients. CME Group, trading at $305.11, is drawing attention after reporting all time record volumes across multiple asset classes and pushing further into round the clock trading. The stock is up 13.1% year to date and...

Millicom International Cellular: Recent Performance Snapshot Millicom International Cellular (TIGO) has caught investor attention after a strong run, with the stock showing gains over the past week, month and past 3 months that outpace its recent daily move. With a recent close of $79.64 and a market value of about $12.88b, investors are weighing this price action against Millicom’s reported $5,819.0 in revenue, $1,316.0 in net income and a value score of 5. See our latest analysis for...

If you are wondering whether Pool's current share price lines up with its underlying value, this article walks through the numbers so you can judge that for yourself. Pool last closed at US$202.93, with returns of 0.9% over 7 days, an 8.3% decline over 30 days, an 11.7% decline year to date and a 34.1% decline over 1 year that many investors are watching closely. Over the past few months, coverage of Pool has focused on how the share price performance compares with broader retail...